Recent Submissions

  • The HFEA public consultation process on hybrids and chimeras: informed, effective, and meaningful? 

    Baylis, F.. 2009. "The HFEA public consultation process on hybrids and chimeras: informed, effective, and meaningful?." Kennedy Institute of Ethics journal 19(1): 41-62.
    In September 2007, the Human Fertilisation and Embryology Authority (HFEA) in the United Kingdom concluded that "there is no fundamental reason to prevent cytoplasmic hybrid research ... this area of research can, with ...
  • Paraconsistent Logic: The View from the Right 

    Schotch, Peter K.. 1992. "Paraconsistent Logic: The View from the Right." PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1992(, Volume Two: Symposia and Invited Papers): 421-429. Copyright © 1992 The Philosophy of Science Association.
    "The best known approaches to "reasoning with inconsistent data" require a logical framework which is decidedly non-classical. An alternative is presented here, beginning with some motivation which has been surprised ...
  • Assuring, Threatening, a Fully Maximizing Theory of Practical Rationality, and the Practical Duties of Agents 

    MacIntosh, Duncan. 2013. "Assuring, Threatening, a Fully Maximizing Theory of Practical Rationality, and the Practical Duties of Agents." Ethics 123(4): 625-656.
    No abstract available.
  • The Cultural Theory of Race: Yet Another Look at Du Bois's "The Conservation of Races" 

    Jeffers, Chike. 2013. "The Cultural Theory of Race: Yet Another Look at Du Bois's "The Conservation of Races"." Ethics 123(3): 403-426.
    No abstract available.
  • Introduction to "The Development of a People" 

    Gooding-Williams, Robert, and Chike Jeffers. 2013. "Introduction to "The Development of a People"." Ethics 123(3): 521-524.
    An introduction is presented in which the reprinting of "The Development of a People," an essay on race by African-American scholar and activist William Edward Burghardt du Bois, within the issue is discussed.
  • VALUING EVIDENCE: bias and the evidence hierarchy of evidence-based medicine 

    Borgerson, Kirstin. 2009. "VALUING EVIDENCE: bias and the evidence hierarchy of evidence-based medicine." Perspectives in Biology & Medicine 52(2): 218-233. Copyright © 2009 The Johns Hopkins University Press. This article first appeared in Perspectives in Biology & Medicine 52(2), Spring 2009, pages 218-233.
    No abstract available.
  • Evidence-Based Alternative Medicine? 

    Borgerson, Kirstin. 2005. "Evidence-Based Alternative Medicine?." Perspectives in Biology & Medicine 48(4): 502-515. Copyright © 2005 The Johns Hopkins University Press. This article first appeared in Perspectives in Biology & Medicine 48(4), Autumn 2005, pages 502-515.
    Focuses on the controversy over the validity of evidence-based medicine (EBM). Proposal for a hierarchy of evidence according to which randomized controlled trials (RCT) and meta-analyses of RCT provide the most reliable ...
  • The Nature of Evidence in Evidence-Based Medicine 

    Goldenberg, Maya J., Kirstin Borgerson, and Robyn Bluhm. 2009. "The Nature of Evidence in Evidence-Based Medicine." Perspectives in Biology & Medicine 52(2): 164-167. Copyright © 2009 The Johns Hopkins University Press. This article first appeared in Perspectives in Biology & Medicine 52(2): Spring 2009, pages 164-167.
    The article focuses on the examination of evidence-based medicine (EBM) in medicine. EBM's contribution in the clinical practice has long been used in the development of institutional and professional guidelines in ...
  • Promises and perils of cognitive performance tools: A dialogue 

    Viirre, E., Baylis, F., & Downie, J. (2007). Promises and perils of cognitive performance tools: A dialogue. Technology 11, Supplement 1, 9-25. doi: 10.3727/107292408786938853
    Cognitive performance tools are evolving and their application is expanding rapidly. Although these tools promise significant advantages, they also raise a number of significant ethical and social concerns. This paper ...
  • Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570]. 

    Baylis, F & Downie, J. (2011) Confusion worse confounded. British Medical Journal [Rapid Response: Withdrawal of clinical trials policy by Canadian research institute is a “lost opportunity for increased transparency” by Ann Silversides. British Medical Journal 2011;342:d2570]. Available at; http://www.bmj.com/content/342/bmj.d2570/reply
    Rapid response to "Withdrawal of clinical trials policy by Canadian research institute is a 'lost opportunity for increased transparency'" by Ann Silversides.
  • Access to health care for women. [Letter to the Editor] 

    Baylis, F., & Nelson, H. L. (1997). Access to health care for women. [Letter to the Editor] New England Journal of Medicine, 336, 1841.
    Letter to the editor
  • Chimera Research and Stem Cell Therapies for Human Neurodegenerative Disorders 

    Baylis, F. & Fenton, A. (2007). Chimera research and stem cell therapies for human neurodegenerative disorders. Cambridge Quarterly of Healthcare Ethics, 16, 195-208. DOI:10.1017/S0963180107070211
    In April 2005, the U.S. National Academy of Sciences (NAS) published its Guidelines for Human Embryonic Stem Cell Research. These voluntary guidelines are among the most permissive in the world—in a country that prohibits ...